Literature DB >> 24866244

Cancer-testis antigen HCA587/MAGE-C2 interacts with BS69 and promotes its degradation in the ubiquitin-proteasome pathway.

Jiaqing Hao1, Rui Shen1, Yan Li1, Yu Zhang1, Yanhui Yin2.   

Abstract

HCA587, also known as MAGE-C2, belonging to the MAGE gene family which is characterized by a conserved MAGE Homology Domain, is active in various types of tumors and silent in normal tissues except in male germ-line cells. The biological function of HCA587 is largely unknown. To analyze it, we attempted to identify protein partners of HCA587. We immunopurified HCA587-containing complex from HEK293 cells and identified BS69, a potential tumor suppressor, as an associated protein by mass spectrometry, and the following Immunoprecipitation and GST pull-down assays confirmed HCA587 interaction with BS69. Interestingly, overexpression of HCA587 promoted ubiquitination and the proteasomal degradation of BS69 whereas knockdown of endogenous HCA587 increased the protein level of BS69. Consistent with a functional role for BS69 in negatively regulating LMP1-induced NF-κB activation, overexpression of HCA587 resulted in a significant enhancement of LMP1-induced IL-6 production. These data indicate that HCA587 is a new negative regulator of BS69.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BS69; Cancer–testis antigen; HCA587; Ubiquitination

Mesh:

Substances:

Year:  2014        PMID: 24866244     DOI: 10.1016/j.bbrc.2014.05.078

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

2.  Suppression of MAGE-A10 alters the metastatic phenotype of tongue squamous cell carcinoma cells.

Authors:  Bruna Dos Santos Mendonça; Michelle Agostini; Iara Gonçalves Aquino; Wagner Barbosa Dias; Débora Campanella Bastos; Franklin D Rumjanek
Journal:  Biochem Biophys Rep       Date:  2017-04-19

Review 3.  Targeted protein degradation in mammalian cells: A promising avenue toward future.

Authors:  Tianyi Zhang; Chuanyang Liu; Wenying Li; Jingyu Kuang; Xin-Yuan Qiu; Lu Min; Lingyun Zhu
Journal:  Comput Struct Biotechnol J       Date:  2022-09-28       Impact factor: 6.155

4.  Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers.

Authors:  Emmanuel B Omole; Iqbal Aijaz; James Ellegate; Emily Isenhart; Mohamed M Desouki; Michalis Mastri; Kristen Humphrey; Emily M Dougherty; Spencer R Rosario; Kent L Nastiuk; Joyce E Ohm; Kevin H Eng
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

5.  Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma.

Authors:  Xiaotong Sun; Zhongtian Jin; Xiao Song; Jingjing Wang; Yan Li; Xiaoping Qian; Yu zhang; Yanhui Yin
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

6.  Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E.

Authors:  Jiaqing Hao; Xiao Song; Jingjing Wang; Chengli Guo; Yan Li; Bing Li; Yu Zhang; Yanhui Yin
Journal:  Oncotarget       Date:  2015-12-08

7.  Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells.

Authors:  Xiao Song; Chengli Guo; Yutian Zheng; Ying Wang; Zhongtian Jin; Yanhui Yin
Journal:  BMC Cancer       Date:  2018-10-11       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.